Randolph, G. J. Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. Curr. Opin. Lipidol.19, 462–468 (2008). ArticleCASPubMedPubMed Central Google Scholar
Feig, J. E. et al. Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation123, 989–998 (2011). This study describes the use of Reversa mice as a model of atherosclerosis regression. ArticleCASPubMedPubMed Central Google Scholar
Feig, J. E. et al. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl Acad. Sci. USA108, 7166–7171 (2011). ArticleCASPubMedPubMed Central Google Scholar
Llodra, J. et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl Acad. Sci. USA101, 11779–11784 (2004). This study shows the emigration of CD68+ cells from regressing atherosclerotic plaques. ArticleCASPubMedPubMed Central Google Scholar
Averill, L. E., Meagher, R. C. & Gerrity, R. G. Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine. Am. J. Pathol.135, 369–377 (1989). CASPubMedPubMed Central Google Scholar
Feldman, D. L., Mogelesky, T. C., Liptak, B. F. & Gerrity, R. G. Leukocytosis in rabbits with diet-induced atherosclerosis. Arterioscler. Thromb.11, 985–994 (1991). ArticleCASPubMed Google Scholar
Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest.117, 195–205 (2007). This study shows thatApoe−/−mice have a monocytosis that is due to an increase in the LY6Chimonocyte population. ArticleCASPubMedPubMed Central Google Scholar
Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest.117, 185–194 (2007). This study shows thatApoe−/−mice have a monocytosis and it describes the chemokine receptors that contribute to monocyte recruitment in progressing plaques. ArticleCASPubMedPubMed Central Google Scholar
Yvan-Charvet, L. et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science328, 1689–1693 (2010). This study establishes the essential role of cellular cholesterol efflux in suppressing haematopoietic stem cell proliferation. ArticleCASPubMedPubMed Central Google Scholar
Tabas, I., Williams, K. J. & Boren, J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation116, 1832–1844 (2007). ArticleCASPubMed Google Scholar
Paulson, K. E. et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res.106, 383–390 (2010). ArticleCASPubMed Google Scholar
Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature Rev. Immunol.7, 678–689 (2007). ArticleCAS Google Scholar
Soehnlein, O. et al. Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol. Med.5, 471–481 (2013). ArticleCASPubMedPubMed Central Google Scholar
Woollard, K. J. & Geissmann, F. Monocytes in atherosclerosis: subsets and functions. Nature Rev. Cardiol.7, 77–86 (2010). Article Google Scholar
Weber, C. & Noels, H. Atherosclerosis: current pathogenesis and therapeutic options. Nature Med.17, 1410–1422 (2011). ArticleCASPubMed Google Scholar
Combadiere, C. et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation117, 1649–1657 (2008). ArticleCASPubMed Google Scholar
Serbina, N. V. & Pamer, E. G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nature Immunol.7, 311–317 (2006). ArticleCAS Google Scholar
Landsman, L. et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood113, 963–972 (2009). ArticleCASPubMed Google Scholar
van Gils, J. M. et al. Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions. Arterioscler. Thromb. Vasc. Biol.33, 911–919 (2013). This study shows that neuronal guidance molecules are differentially expressed on the endothelium in athero-prone and athero-protected regions of the vasculature. ArticleCASPubMedPubMed Central Google Scholar
van Gils, J. M. et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nature Immunol.13, 136–143 (2012). This work identifies netrin 1 as a retention signal that blocks macrophage egress from inflamed vessel walls in the presence of hypercholesterolaemia, which leads to chronic vessel wall inflammation and plaque progression. ArticleCAS Google Scholar
Wanschel, A. et al. Neuroimmune guidance cue semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention. Arterioscler. Thromb. Vasc. Biol.33, 886–893 (2013). ArticleCASPubMedPubMed Central Google Scholar
Moore, K. J. & Freeman, M. W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol.26, 1702–1711 (2006). ArticleCASPubMed Google Scholar
Miller, Y. I. et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res.108, 235–248 (2011). ArticleCASPubMedPubMed Central Google Scholar
Kunjathoor, V. V. et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem.277, 49982–49988 (2002). ArticleCASPubMed Google Scholar
Podrez, E. A., Schmitt, D., Hoff, H. F. & Hazen, S. L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest.103, 1547–1560 (1999). ArticleCASPubMedPubMed Central Google Scholar
Kzhyshkowska, J., Neyen, C. & Gordon, S. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology217, 492–502 (2012). ArticleCASPubMed Google Scholar
Maxfield, F. R. & Tabas, I. Role of cholesterol and lipid organization in disease. Nature438, 612–621 (2005). ArticleCASPubMed Google Scholar
Kuchibhotla, S. et al. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc. Res.78, 185–196 (2008). ArticleCASPubMed Google Scholar
Manning-Tobin, J. J. et al. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol.29, 19–26 (2009). ArticleCASPubMed Google Scholar
Boyanovsky, B. B., van der Westhuyzen, D. R. & Webb, N. R. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans. J. Biol. Chem.280, 32746–32752 (2005). ArticleCASPubMed Google Scholar
Oorni, K. & Kovanen, P. T. Lipoprotein modification by secretory phospholipase A2 enzymes contributes to the initiation and progression of atherosclerosis. Curr. Opin. Lipidol.20, 421–427 (2009). ArticleCASPubMed Google Scholar
Lind, L. et al. Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality. Eur. Heart J.33, 2946–2954 (2012). ArticleCASPubMed Google Scholar
Kugiyama, K. et al. Circulating levels of secretory type II phospholipase A2 predict coronary events in patients with coronary artery disease. Circulation100, 1280–1284 (1999). ArticleCASPubMed Google Scholar
Kruth, H. S. Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles. Curr. Opin. Lipidol.22, 386–393 (2011). This is a discussion of studies that establish that native LDL can contribute to foam cell formation through its uptake via macrophage fluid-phase pinocytosis. ArticleCASPubMedPubMed Central Google Scholar
Zhu, X. et al. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res.51, 3196–3206 (2010). This study shows that cholesterol enrichment of lipid rafts promotes signalling via TLRs. ArticleCASPubMedPubMed Central Google Scholar
Mogilenko, D. A. et al. Endogenous apolipoprotein A-I stabilizes ATP-binding cassette transporter A1 and modulates Toll-like receptor 4 signaling in human macrophages. FASEB J.26, 2019–2030 (2012). ArticleCASPubMed Google Scholar
Yvan-Charvet, L. et al. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation118, 1837–1847 (2008). ArticleCASPubMedPubMed Central Google Scholar
Jerome, W. G. Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder. Rejuven. Res.9, 245–255 (2006). ArticleCAS Google Scholar
Feng, B. et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nature Cell Biol.5, 781–792 (2003). ArticleCASPubMed Google Scholar
Tabas, I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol.25, 2255–2264 (2005). ArticleCASPubMed Google Scholar
Yvan-Charvet, L., Wang, N. & Tall, A. R. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol.30, 139–143 (2010). ArticleCASPubMed Google Scholar
Spann, N. J. et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell151, 138–152 (2012). ArticleCASPubMedPubMed Central Google Scholar
Calkin, A. C. & Tontonoz, P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nature Rev. Mol. Cell Biol.13, 213–224 (2012). ArticleCAS Google Scholar
Singh, R. et al. Autophagy regulates lipid metabolism. Nature458, 1131–1135 (2009). This study was the first to show a role for autophagy in regulating lipid metabolism. ArticleCASPubMedPubMed Central Google Scholar
Ouimet, M. et al. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell. Metab.13, 655–667 (2011). This study shows that autophagy regulates cholesterol efflux in macrophage foam cells. ArticleCASPubMedPubMed Central Google Scholar
Liao, X. et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell. Metab.15, 545–553 (2012). This study uncovers a protective role for the autophagy process in atherosclerosis through the regulation of plaque necrosis. ArticleCASPubMedPubMed Central Google Scholar
Razani, B. et al. Autophagy links inflammasomes to atherosclerotic progression. Cell. Metab.15, 534–544 (2012). This study shows a protective role for the autophagy process in atherosclerosis through the regulation of inflammasome activation. ArticleCASPubMedPubMed Central Google Scholar
Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunol.12, 222–230 (2011). ArticleCAS Google Scholar
Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature456, 264–268 (2008). ArticleCASPubMed Google Scholar
Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature464, 1357–1361 (2010). This study describes a role for the NLRP3 inflammasome in atherogenesis, thereby uncovering a previously unappreciated role of cholesterol crystals as key early initiators of vascular inflammation. ArticleCASPubMedPubMed Central Google Scholar
Lim, R. S. et al. Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J. Lipid Res.52, 2177–2186 (2011). ArticleCASPubMedPubMed Central Google Scholar
Gage, J., Hasu, M., Thabet, M. & Whitman, S. C. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can. J. Cardiol.28, 222–229 (2012). ArticleCASPubMed Google Scholar
Usui, F. et al. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem. Biophys. Res. Commun.425, 162–168 (2012). ArticleCASPubMed Google Scholar
Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunol.9, 847–856 (2008). ArticleCAS Google Scholar
Freigang, S. et al. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur. J. Immunol.41, 2040–2051 (2011). ArticleCASPubMed Google Scholar
Menu, P. et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis.2, e137 (2011). ArticleCASPubMedPubMed Central Google Scholar
Sheedy, F. J. et al. CD36 coordinates activation of the NLRP3 inflammasome by facilitating the intracellular nucleation of soluble to particulate ligands in sterile inflammation. Nature Immunol.14, 812–820 (2013). ArticleCAS Google Scholar
Niemi, K. et al. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J. Immunol.186, 6119–6128 (2011). ArticleCASPubMed Google Scholar
Michelsen, K. S. et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl Acad. Sci. USA101, 10679–10684 (2004). ArticleCASPubMedPubMed Central Google Scholar
Mullick, A. E., Tobias, P. S. & Curtiss, L. K. Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest.115, 3149–3156 (2005). ArticleCASPubMedPubMed Central Google Scholar
Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunol.11, 155–161 (2010). This study identifies a new TLR heterodimer, TLR4–TLR6, that is triggered by oxidized LDL through CD36 and that promotes pro-inflammatory signalling in macrophages. ArticleCAS Google Scholar
Ding, Y. et al. Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol.32, 1596–1604 (2012). ArticleCASPubMedPubMed Central Google Scholar
Kim, T. W. et al. The critical role of IL-1 receptor-associated kinase 4-mediated NF-κB activation in modified low-density lipoprotein-induced inflammatory gene expression and atherosclerosis. J. Immunol.186, 2871–2880 (2011). ArticleCASPubMed Google Scholar
Rekhter, M. et al. Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation. Biochem. Biophys. Res. Commun.367, 642–648 (2008). ArticleCASPubMed Google Scholar
Lutgens, E. et al. Deficient CD40–TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J. Exp. Med.207, 391–404 (2010). ArticleCASPubMedPubMed Central Google Scholar
Richards, M. R. et al. The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice. Innate Immun.19, 20–29 (2013). ArticleCASPubMed Google Scholar
Bjorkbacka, H. et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nature Med.10, 416–421 (2004). ArticleCASPubMed Google Scholar
Bae, Y. S. et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res.104, 210–218 (2009). ArticleCASPubMed Google Scholar
Seimon, T. A. et al. Atherogenic lipids and lipoproteins trigger CD36–TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell. Metab.12, 467–482 (2010). ArticleCASPubMedPubMed Central Google Scholar
Zhu, X. et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem.283, 22930–22941 (2008). ArticleCASPubMedPubMed Central Google Scholar
Adamson, S. & Leitinger, N. Phenotypic modulation of macrophages in response to plaque lipids. Curr. Opin. Lipidol.22, 335–342 (2011). ArticleCASPubMedPubMed Central Google Scholar
Chinetti-Gbaguidi, G. et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ. Res.108, 985–995 (2011). ArticleCASPubMedPubMed Central Google Scholar
Gallardo-Soler, A. et al. Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-γ/δ-mediated effect that links lipid metabolism and immunity. Mol. Endocrinol.22, 1394–1402 (2008). ArticleCASPubMedPubMed Central Google Scholar
Kadl, A. et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ. Res.107, 737–746 (2010). This study identifies a new macrophage phenotype, termed the Mox macrophage, that occurs in macrophages that have been exposed to atherogenic phospholipids. ArticleCASPubMedPubMed Central Google Scholar
Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nature Immunol.12, 204–212 (2011). ArticleCAS Google Scholar
Hanna, R. N. et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C− monocytes. Nature Immunol.12, 778–785 (2011). This study identifies an important role for NR4A1 in M2 macrophage polarization. ArticleCAS Google Scholar
Hanna, R. N. et al. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ. Res.110, 416–427 (2012). This study reports that the deletion of NR4A1 worsens atherosclerosis by increasing macrophage polarization to the M1 phenotype. ArticleCASPubMed Google Scholar
Hamers, A. A. et al. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ. Res.110, 428–438 (2012). This study reports that deletion of NR4A1 worsens atherosclerosis and inflammation. ArticleCASPubMed Google Scholar
Chao, L. C. et al. Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice. J. Lipid Res.54, 806–815 (2013). In contrast to references 83 and 84, this study finds no role for NR4A1 in macrophage polarization or atherogenesis. ArticleCASPubMedPubMed Central Google Scholar
Liao, X. et al. Krüppel-like factor 4 regulates macrophage polarization. J. Clin. Invest.121, 2736–2749 (2011). This study identifies a key role for the transcription factor KLF4 in directing M2 macrophage polarization. ArticleCASPubMedPubMed Central Google Scholar
Sharma, N. et al. Myeloid Krüppel-like factor 4 deficiency augments atherogenesis in _ApoE_−/− mice — brief report. Arterioscler. Thromb. Vasc. Biol.32, 2836–2838 (2012). This study shows that the deletion of KLF4 leads to enhanced atherosclerosis in both chow-fed and Western diet-fedApoe−/−mice. ArticleCASPubMedPubMed Central Google Scholar
Cardilo-Reis, L. et al. Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol. Med.4, 1072–1086 (2012). ArticleCASPubMedPubMed Central Google Scholar
Rayner, K. J. et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest.121, 2921–2931 (2011). ArticleCASPubMedPubMed Central Google Scholar
Jenkins, S. J. et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science332, 1284–1288 (2011). ArticleCASPubMedPubMed Central Google Scholar
Zhu, S. N., Chen, M., Jongstra-Bilen, J. & Cybulsky, M. I. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med.206, 2141–2149 (2009). ArticleCASPubMedPubMed Central Google Scholar
Gerrity, R. G. & Naito, H. K. Lipid clearance from fatty streak lesions by foam cell migration. Artery8, 215–219 (1980). CASPubMed Google Scholar
Ramkhelawon, B. et al. Hypoxia induces netrin-1 and unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival. Arterioscler Thromb. Vasc. Biol.33, 1180–1188 (2013). ArticleCASPubMedPubMed Central Google Scholar
Parathath, S. et al. Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism. Circ. Res.109, 1141–1152 (2011). ArticleCASPubMedPubMed Central Google Scholar
Feig, J. E. et al. Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS ONE7, e39790 (2012). Through transcriptome analysis of macrophages in progressing and regressing plaques, this work identifies the genetic signature of macrophages during the resolution of atherosclerotic inflammation. ArticleCASPubMedPubMed Central Google Scholar
Trogan, E. et al. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc. Natl Acad. Sci. USA99, 2234–2239 (2002). ArticleCASPubMedPubMed Central Google Scholar
Yvan-Charvet, L. et al. ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circ. Res.106, 1861–1869 (2010). ArticleCASPubMedPubMed Central Google Scholar
Potteaux, S. et al. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of _Apoe_−/− mice during disease regression. J. Clin. Invest.121, 2025–2036 (2011). In this model of atherosclerosis regression, which was achieved through the reconstitution ofApoe−/−mice with APOE, the authors show that reduced monocyte recruitment and increased apoptotic turnover of macrophages are crucial components of atherosclerosis resolution. ArticleCASPubMedPubMed Central Google Scholar
Nagareddy, P. R. et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell. Metab.17, 695–708 (2013). ArticleCASPubMedPubMed Central Google Scholar
Raffai, R. L. & Weisgraber, K. H. Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J. Biol. Chem.277, 11064–11068 (2002). ArticleCASPubMed Google Scholar
Reis, E. D. et al. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J. Vasc. Surg.34, 541–547 (2001). ArticleCASPubMed Google Scholar
Rong, J. X. et al. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation104, 2447–2452 (2001). This study reports that atherosclerosis regression that is induced by increased HDL levels is characterized by decreasing macrophage content and increasing smooth muscle cell content. ArticleCASPubMed Google Scholar
Feig, J. E. et al. Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. PLoS ONE6, e28534 (2011). ArticleCASPubMedPubMed Central Google Scholar
Frias, J. C., Ma, Y., Williams, K. J., Fayad, Z. A. & Fisher, E. A. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett.6, 2220–2224 (2006). ArticleCASPubMed Google Scholar
Leuschner, F. et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nature Biotech.29, 1005–1010 (2011). ArticleCAS Google Scholar
Egawa, M. et al. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity38, 570–580 (2013). ArticleCASPubMed Google Scholar
Denney, L. et al. Activation of invariant NKT cells in early phase of experimental autoimmune encephalomyelitis results in differentiation of Ly6Chi inflammatory monocyte to M2 macrophages and improved outcome. J. Immunol.189, 551–557 (2012). ArticleCASPubMed Google Scholar
Schrijvers, D. M., De Meyer, G. R. & Martinet, W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler. Thromb. Vasc. Biol.31, 2787–2791 (2011). ArticleCASPubMed Google Scholar
Thorp, E., Cui, D., Schrijvers, D. M., Kuriakose, G. & Tabas, I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of _apoe_−/− mice. Arterioscler. Thromb. Vasc. Biol.28, 1421–1428 (2008). ArticleCASPubMedPubMed Central Google Scholar
Zizzo, G., Hilliard, B. A., Monestier, M. & Cohen, P. L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J. Immunol.189, 3508–3520 (2012). ArticleCASPubMed Google Scholar
Plump, A. S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell71, 343–353 (1992). ArticleCASPubMed Google Scholar
Zhang, S. H., Reddick, R. L., Piedrahita, J. A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science258, 468–471 (1992). ArticleCASPubMed Google Scholar
Ishibashi, S. et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest.92, 883–893 (1993). ArticleCASPubMedPubMed Central Google Scholar
Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nature Med.http://dx.doi.org/10.1038/nm.3258 (2013).